Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing Bles versus Curosurf in respiratory distress of preterm infants
IRCT2017021418994N3Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of BLES and Poractant alfa in respiratory distress syndrome (RDS) (2 arms), sponsored by Kerman University of Medical Sciences. Started Jun 2016; status: completed.
02
Drugs
BLESPoractant alfa
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT2017021418994N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017021418994N3.